Department of Urology and Laboratory of Pelvic Floor Muscle Function, Shenzhen Children's Hospital, Futian District, Shenzhen, 518000, Guangdong, China.
Department of Laboratory Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434020, China.
Eur J Pediatr. 2023 Apr;182(4):1823-1828. doi: 10.1007/s00431-023-04859-8. Epub 2023 Feb 16.
Prepubertal testicular teratomas are rare tumors with limited practical guidance for their management. This study aimed to analyze a large multicenter database to establish the optimal management of testicular teratomas. We retrospectively collected data on testicular teratomas in children younger than 12 years who underwent surgery without postoperative chemotherapy in three large professional children's institutions in China between 2007 and 2021. The biological behavior and long-term outcomes of testicular teratomas were analyzed. In total, 487 children (with 393 mature teratomas and 94 immature teratomas) were included. Among mature teratomas, 375 cases were testis-sparing, 18 were orchiectomies, 346 were operated through the scrotal approach, and 47 underwent the inguinal approach. The median follow-up period was 70 months, and no recurrence or testicular atrophy was observed. Among the children with immature teratomas, 54 underwent testis-sparing surgery, 40 underwent orchiectomy, 43 were operated through the scrotal approach, and 51 were operated through the inguinal approach. Two cases of immature teratomas with cryptorchidism had local recurrence or metastasis within 1 year of the operation. The median follow-up duration was 76 months. No other patients had recurrence, metastasis, or testicular atrophy. Conclusion: Testicular-sparing surgery is the first treatment choice for prepubertal testicular teratomas, with the scrotal approach being a safe and well-tolerated strategy for these diseases. Additionally, patients with immature teratomas and cryptorchidism may have tumor recurrence or metastasis after surgery. Therefore, these patients should be closely followed up in the first year after surgery. What is Known: • There is a fundamental difference between testicular tumours in childhood and those in adulthood - not only in terms of the difference and incidence but also in terms of histology. • For surgical techniques, the inguinal approach is recommended for the treatment of testicular teratomas in children. What is New: • The scrotal approach being a safe and well-tolerated strategy for testicular teratomas in children. • Patients with immature teratomas and cryptorchidism may have tumor recurrence or metastasis after surgery. These patients should be closely followed up in the first year after surgery.
青春期前睾丸畸胎瘤是罕见的肿瘤,其管理方法有限。本研究旨在分析大型多中心数据库,以确定睾丸畸胎瘤的最佳治疗方法。我们回顾性收集了 2007 年至 2021 年期间中国 3 家大型专业儿童医院接受手术且术后未行化疗的 12 岁以下儿童睾丸畸胎瘤患者的数据。分析睾丸畸胎瘤的生物学行为和长期结果。共纳入 487 例儿童(393 例成熟畸胎瘤和 94 例未成熟畸胎瘤)。在成熟畸胎瘤中,375 例行保留睾丸手术,18 例行睾丸切除术,346 例经阴囊入路手术,47 例行腹股沟入路手术。中位随访时间为 70 个月,未观察到复发或睾丸萎缩。在未成熟畸胎瘤患儿中,54 例行保留睾丸手术,40 例行睾丸切除术,43 例行阴囊入路手术,51 例行腹股沟入路手术。2 例隐睾合并未成熟畸胎瘤患儿术后 1 年内局部复发或转移。中位随访时间为 76 个月。其他患儿均无复发、转移或睾丸萎缩。结论:青春期前睾丸畸胎瘤的首选治疗方法是保留睾丸手术,阴囊入路是治疗此类疾病的安全且耐受良好的策略。此外,未成熟畸胎瘤合并隐睾的患儿术后可能有肿瘤复发或转移。因此,这些患者术后应密切随访 1 年。已知:• 儿童期睾丸肿瘤与成人期睾丸肿瘤在性质上存在根本差异——不仅在差异和发生率方面,而且在组织学方面。• 对于手术技术,建议采用腹股沟入路治疗儿童睾丸畸胎瘤。新发现:• 阴囊入路是治疗儿童睾丸畸胎瘤的安全且耐受良好的策略。• 未成熟畸胎瘤合并隐睾的患儿术后可能有肿瘤复发或转移。这些患者术后应密切随访 1 年。